These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 19564254)

  • 41. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
    Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.
    Gertz RE; Li Z; Pimenta FC; Jackson D; Juni BA; Lynfield R; Jorgensen JH; Carvalho Mda G; Beall BW;
    J Infect Dis; 2010 Mar; 201(5):770-5. PubMed ID: 20178139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
    Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
    Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
    Park SY; Moore MR; Bruden DL; Hyde TB; Reasonover AL; Harker-Jones M; Rudolph KM; Hurlburt DA; Parks DJ; Parkinson AJ; Schuchat A; Hennessy TW
    Pediatr Infect Dis J; 2008 Apr; 27(4):335-40. PubMed ID: 18316986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.
    Galanis I; Lindstrand A; Darenberg J; Browall S; Nannapaneni P; Sjöström K; Morfeldt E; Naucler P; Blennow M; Örtqvist Å; Henriques-Normark B
    Eur Respir J; 2016 Apr; 47(4):1208-18. PubMed ID: 26797033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-vaccine serotype pneumococcal carriage in healthy infants in South Africa following introduction of the 13-valent pneumococcal conjugate vaccine.
    Skosana Z; Von Gottberg A; Olorunju S; Mohale T; Du Plessis M; Adams T; Mbelle N
    S Afr Med J; 2021 Feb; 111(2):143-148. PubMed ID: 33944725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine.
    Nahm MH; Lin J; Finkelstein JA; Pelton SI
    J Infect Dis; 2009 Feb; 199(3):320-5. PubMed ID: 19099489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines.
    McElligott M; Vickers I; Cafferkey M; Cunney R; Humphreys H
    Vaccine; 2014 Jun; 32(28):3495-500. PubMed ID: 24795223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.
    Lindstrand A; Galanis I; Darenberg J; Morfeldt E; Naucler P; Blennow M; Alfvén T; Henriques-Normark B; Örtqvist Å
    Vaccine; 2016 Aug; 34(38):4565-4571. PubMed ID: 27473304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.
    Sá-Leão R; Nunes S; Brito-Avô A; Frazão N; Simões AS; Crisóstomo MI; Paulo AC; Saldanha J; Santos-Sanches I; de Lencastre H
    Clin Microbiol Infect; 2009 Nov; 15(11):1002-7. PubMed ID: 19392883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of thirteen-valent pneumococcal conjugate vaccine on nasopharyngeal carriage in healthy children under 24 months in Okinawa, Japan.
    Chang B; Akeda H; Nakamura Y; Hamabata H; Ameku K; Toma T; Miyagi M; Ohnishi M
    J Infect Chemother; 2020 May; 26(5):465-470. PubMed ID: 31926843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penicillin resistance and serotype distribution of Streptococcus pneumoniae in nasopharyngeal carrier children under 5 years of age in Dar es Salaam, Tanzania.
    Moyo SJ; Steinbakk M; Aboud S; Mkopi N; Kasubi M; Blomberg B; Manji K; Lyamuya EF; Maselle SY; Langeland N
    J Med Microbiol; 2012 Jul; 61(Pt 7):952-959. PubMed ID: 22442292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
    Kovács E; Sahin-Tóth J; Tóthpál A; Kristóf K; van der Linden M; Tirczka T; Dobay O
    Vaccine; 2019 Jan; 37(1):99-108. PubMed ID: 30470639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece.
    Grivea IN; Panagiotou M; Tsantouli AG; Syrogiannopoulos GA
    Pediatr Infect Dis J; 2008 Jun; 27(6):519-25. PubMed ID: 18469733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
    Pelton SI; Huot H; Finkelstein JA; Bishop CJ; Hsu KK; Kellenberg J; Huang SS; Goldstein R; Hanage WP
    Pediatr Infect Dis J; 2007 Jun; 26(6):468-72. PubMed ID: 17529860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
    Hadjipanayis A; Efstathiou E; Alexandrou M; Panayiotou L; Zachariadou C; Petrou P; Papaevangelou V
    PLoS One; 2016; 11(10):e0163269. PubMed ID: 27706247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.